Novonesis provides outlook for 2024 with expected 5-7% organic sales growth and ~35% adj. EBITDA margin. Pro forma financials disclosed. Ester Baiget, CEO of Novonesis, said: “Today we provide key pro ...
Freight Technologies, Inc. (Nasdaq: FRGT, “Fr8Tech” or the “Company”), a logistics management innovation company offering a diverse portfolio of technology-driven solutions, today released the ...
The MarketWatch News Department was not involved in the creation of this content. SINGAPORE, Aug. 29, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd (NASDAQ: GCL) ("GCL" or the "Company"), a leading ...
Auddia Inc. (NASDAQ:AUUD) filed an 8-K with the Securities and Exchange Commission on Friday, providing audited financial statements of Thramann Holdings, LLC and its subsidiaries for the years ended ...
AtaiBeckley Inc. (NASDAQ:ATAI) filed a report Friday with the U.S. Securities and Exchange Commission providing additional information related to its acquisition of Beckley Psytech Limited, a company ...
Hosted on MSN
RedHill Biopharma files pro forma financials after Talicia joint venture deal with Cumberland
The latest announcement is out from RedHill Biopharma ( (RDHL)). On October 17, 2025, RedHill Biopharma completed a strategic transaction with Cumberland Pharmaceuticals involving Talicia®, its ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results